WO03030833A3
Angiopoietin-2 specific binding agents
Abstract
Disclosed are specific binding agents, such as fully human antibodies, that bind to angiopoietin-2. Also disclosed are heavy chain fragments, light chain fragments, and CDRs of the antibodies, as well as methods of making and using the antibodies.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
Every citation, both ways
| Document | Relation | Office | Category | Cited during |
|---|---|---|---|---|
| US2003082177A1 | Cites | United States of America | A | International search |
| US6455035B1 | Cites | United States of America | A | International search |
82 members in 26 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 32860401 | United States of America | P | |
| 32860401 | United States of America | P | |
| 26980502 | United States of America | A | |
| 26980502 | United States of America | A | |
| 10269805 | – | – | – |
| 10269805 | – | – | – |
| 60328604 | – | – | – |
| US20010328604P | – | – | – |
| US20020269805 | – | – | – |
Members82
| Document | Office | Kind | |
|---|---|---|---|
| CA2461435A1 | Canada | A1 | |
| WO03030833A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2003124129A1 | United States of America | A1 | |
| NO20041907L | Norway | L | |
| KR20040051606A | Republic of Korea | A | |
| MXPA04003345A | Mexico | A | |
| IL161021A0 | Israel | A0 | |
| WO03030833A3This record | World Intellectual Property Organization (WIPO) | A3 | |
| EP1495053A2 | European Patent Office (EPO) | A2 | |
| JP2005506067A | Japan | A | |
| CN1602317A | China | A | |
| HK1072775A | Hong Kong, China | A | |
| HK1072775A1 | Hong Kong, China | A1 | |
| PL373911A1 | Poland | A1 | |
| EA200400510A1 | Eurasian Patent Organization (EAPO) | A1 | |
| US2006018909A1 | United States of America | A1 | |
| AU2002343498B2 | Australia | B2 | |
| AU2005295260A1 | Australia | A1 | |
| CA2583910A1 | Canada | A1 | |
| WO2006045049A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP1495053A4 | European Patent Office (EPO) | A4 | |
| RS28904A | Serbia | A | |
| AU2006228095A1 | Australia | A1 | |
| NZ531901A | New Zealand | A | |
| ZA200402392B | South Africa | B | |
| BR0213224A | Brazil | A | |
| MX2007004247A | Mexico | A | |
| EP1805219A1 | European Patent Office (EPO) | A1 | |
| IL182279A0 | Israel | A0 | |
| KR20070085408A | Republic of Korea | A | |
| EA200700876A1 | Eurasian Patent Organization (EAPO) | A1 | |
| MA29015B1 | Morocco | B1 | |
| HU0500994A2 | Hungary | A2 | |
| HUP0500994A2 | Hungary | A2 | |
| JP2008520188A | Japan | A | |
| ZA200704020B | South Africa | B | |
| EA010726B1 | Eurasian Patent Organization (EAPO) | B1 | |
| BRPI0518209A | Brazil | A | |
| RU2007118670A | Russian Federation | A | |
| US7521053B2 | United States of America | B2 | |
| EA011866B1 | Eurasian Patent Organization (EAPO) | B1 | |
| CN101495513A | China | A | |
| US2009191212A1 | United States of America | A1 | |
| JP2009225799A | Japan | A | |
| SG156668A1 | Singapore | A1 | |
| US7658924B2 | United States of America | B2 | |
| CN101671393A | China | A | |
| CN100595211C | China | C | |
| KR20100049682A | Republic of Korea | A | |
| AU2006228095B2 | Australia | B2 | |
| RU2404992C2 | Russian Federation | C2 | |
| EP2272869A2 | European Patent Office (EPO) | A2 | |
| JP4637480B2 | Japan | B2 | |
| AU2011200824A1 | Australia | A1 | |
| NZ575673A | New Zealand | A | |
| RS51437B | Serbia | B | |
| EP2272869A3 | European Patent Office (EPO) | A3 | |
| JP2011207882A | Japan | A | |
| KR101089844B1 | Republic of Korea | B1 | |
| AU2011200824B2 | Australia | B2 | |
| US2011311546A1 | United States of America | A1 | |
| RU2010132956A | Russian Federation | A | |
| HK1152949A | Hong Kong, China | A | |
| HK1152949A1 | Hong Kong, China | A1 | |
| HU0500994A3 | Hungary | A3 | |
| HUP0500994A3 | Hungary | A3 | |
| AU2005295260B2 | Australia | B2 | |
| CA2583910C | Canada | C | |
| EP1495053B1 | European Patent Office (EPO) | B1 | |
| PT1495053E | Portugal | E | |
| DK1495053T3 | Denmark | T3 | |
| SI1495053T1 | Slovenia | T1 | |
| JP5044608B2 | Japan | B2 | |
| ES2389060T3 | Spain | T3 | |
| JP2012210216A | Japan | A | |
| NO332593B1 | Norway | B1 | |
| US2013142799A1 | United States of America | A1 | |
| IL161021A | Israel | A | |
| EP2272869B1 | European Patent Office (EPO) | B1 | |
| ES2439221T3 | Spain | T3 | |
| JP2014040428A | Japan | A | |
| CN101495513B | China | B |
25 legal events, as 2 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Entry into the national phaseENP | ENP | BR | |
| Wipo information: published in national officeWWP | WWP | WO | |
| Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)DFPE | DFPE | WO | |
| Wipo information: published in national officeWWP | WWP | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Ep: the epo has been informed by wipo that ep was designated in this application121 | 121 | WO | |
| Designated statesAK | AK | WO | |
| Designated countries for regional patentsAL | AL | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO |
Numbers
- Publication
- 03/030833
- Publication, DOCDB
- 03030833
- Publication, EPODOC
- WO03030833
- Application
- 32613
- Application, DOCDB
- 0232613
- Application, EPODOC
- WO2002US32613
Titles2
- English
- ANGIOPOIETIN-2 SPECIFIC BINDING AGENTS
- French
- AGENTS DE LIAISON SPÉCIFIQUES DE L'ANGIOPOÏÉTINE-2
Classification
- CPC, 22
- C07K16/22
- C07K16/30
- A61K2039/505
- C07K2317/21
- C07K2317/56
- A61P11/06
- A61P15/00
- A61P17/06
- A61P19/00
- A61P19/02
- A61P19/08
- A61P27/02
- A61P29/00
- A61P3/04
- A61P35/00
- A61P35/02
- A61P43/00
- A61P5/00
- A61P9/00
- A61P9/10
- A61P3/10
- C07K14/515
- IPC, 26
- A61K39 395
- A61K45 00
- A61P3 04
- A61P3 10
- A61P5 00
- A61P9 00
- G01N33 53
- A61P9 10
- A61P11 06
- A61P15 00
- A61P17 06
- A61P19 02
- A61P19 08
- A61P27 02
- A61P29 00
- A61P35 00
- A61P35 02
- A61P43 00
- C07K16 18
- C07K16 22
- C12N1 15
- C12N1 19
- C12N1 21
- C12N5 10
- C12N15 09
- C12P21 08
Designated states4
- Regional, 4
- Zimbabwe
- Turkmenistan
- Türkiye
- Togo